1'-(tert-Butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid

Catalog No. :
ACXAMN270
CAS No. :
2225141-56-8
Molecular Formula :
C16H25NO5
Molecular Weight :
311.38

IUPAC Name:1'-(tert-butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid

1'-(tert-Butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$410.00Login to see priceInquiryInquiry
100mg98%$602.00Login to see priceInquiryInquiry
250mg98%$855.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1'-(tert-Butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid
IUPAC Name1'-(tert-butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid
MDL No.MFCD31665924
Molecular FormulaC16H25NO5
Molecular Weight311.38
SMILESCC(C)(C)OC(=O)N1CCC2(CC1)OC1(C)CC2(C(=O)O)C1
InChI KeyJIKLTOVTPHCCBU-UHFFFAOYSA-N
Synonym1''-[(tert-butoxy)carbonyl]-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4''-piperidine]-1-carboxylic acid;Spiro[2-oxabicyclo[2.1.1]hexane-3,4'-piperidine]-1',4-dicarboxylic acid, 1-methyl-, 1'-(1,1-dimethylethyl) ester;1'-(tert-butoxycarbonyl)-4-methyl-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1-carboxylic acid
CAS No.2225141-56-8

Synthetic Route by SureRoute

1. ACXAMN270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXAMN270 route product structure diagram
    ACXAMN2702225141-56-8
Inquiry

2. ACXAMN270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXAMN270 route product structure diagram
    ACXAMN2702225141-56-8
Inquiry

Comments (0)